NCT01031524
- Conditions
- Infections, Malaria, Malaria, Falciparum, +5 more
- Locations
-
- Department of Ambulatory Care and Community Medicine; University Hospital Lausanne, Switzerland
Clinical trial condition
Plasmodium Falciparum Malaria
Explore clinical trials studying Plasmodium Falciparum Malaria. Study availability and eligibility vary by location and protocol.
66 public trials
1 recruiting study
Plasmodium Falciparum Malaria trial results
Completed
Assessment of Three Formulations of the Candidate Vaccine AMA 1 in Healthy Dutch Adult Volunteers
NCT00730782
- Conditions
- Infections, Malaria, Malaria, Falciparum, +5 more
- Locations
-
- Radboud University Nijmegen Medical Centre Nijmegen, Netherlands
- Biomedical Primate Research Centre Rijswijk, Netherlands
NCT00709969
- Conditions
- Infections, Malaria, Malaria, Falciparum, +5 more
- Locations
-
- Kemri-Wellcome Trust Programme Kilifi, Kenya
- University College Hospital Malaria Research Laboratories Institute for Advance Medical Research and Training Ibadan, Nigeria
- Muhimbili University College of Health Sciences Department of Parasitology and Medical Entomology, Box 65011 Dar es Salaam, Tanzania
Completed
Multi-Centre Trial Comparing Three Artemisinin-Based Combination Treatments on P. Falciparum Malaria
NCT00484900
- Conditions
- Infections, Malaria, Malaria, Falciparum, +5 more
- Locations
-
- Cameroon Baptist Convention Clinic of Biyem-Assi Yaoundé, Cameroon
- Health centres of Samako, Kolle and Bancoumane Bamako, Mali
- Health centres Rwamagana and Muhima Kigali, Rwanda
- Alhara Alola Health centre New Halfa, Sudan
NCT00362050
- Conditions
- Infections, Malaria, Malaria, Falciparum, +5 more
- Locations
-
- Field Station Malaria Reseach Centre (Indian Council of Medical Research) Rourkela, Odisha, India
- Public Health Care Center Kivunge, Zanzibar, Tanzania
- District Hospital Bagamayo Dar es Salaam, Tanzania
- Faculty of Tropical Medicine, 420/6 Rajavithee Road Bangkok, Thailand
Active, Not Recruiting
Assessing the Safety, Immunogenicity and Ex-vivo Efficacy of Two Candidate Malaria Transmission Blocking Vaccines, Pfs25-IMX313 and Pfs45/48 Administered Alone and in Combination, in Matrix-M Adjuvant
NCT06549257
- Conditions
- Infections, Malaria, Malaria, Falciparum, +5 more
- Locations
-
- Institut des Sciences et Techniques (INSTech) Bobo-Dioulasso, Burkina Faso